Skip to main content

TCGX Acquisition Corp.

corporate_fare Company Profile

TCGX Acquisition Corp.

TCGX·NASDAQ·Life Sciences·CIK 0002137965

TCGX Acquisition Corp. is a special purpose acquisition company (SPAC) formed to complete a business combination with one or more businesses. This combination could take the form of a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization. The company was incorporated in 2026 and operates from Palo Alto, California.

TCGX Acquisition Corp. (NASDAQ:TCGX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for TCGX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-19, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for TCGX spans 8-K.

Recent high-impact activity:

  • TCGX to Merge With TriGemX Bio in $160M-PIPE SPAC Deal at ~$599M Equity Value
  • TCGX to Take Migraine Drug Developer TriGemX Public in $246M De-SPAC With $160M PIPE
  • TCGX Acquisition Corp II Files for $100M IPO on Nasdaq

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 74,947 shares in TCGX as of the October 30, 2026 settlement, a 42.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 2.6% of TCGX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)74,947 shares as of October 30, 2026
Change vs prior period▲ 42.8%
Days to cover1.00 at avg daily volume of 408,550
Daily short volume (FINRA facilities)2.6% of 20,073 shares on November 20, 2026
5-day average short volume3.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with T →
$10.04 +0.20% today
52-week range · as of 2026-10-19 $10.04 – $18.91
Market cap
$113.26M
Volume
123.2K (0.7× avg)
3-mo avg 180.1K
Live data · 2026-11-22 06:02 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TCGX - Latest Insights

TCGX
Oct 19, 2026, 9:20 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $12.36
Real-time Price: $10.04 info
Change: -$2.32 (-19%) info
Market Cap: $113.264M info
TCGX
Oct 19, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $12.36
Real-time Price: $10.04 info
Change: -$2.32 (-19%) info
Market Cap: $113.264M info
TCGX
Sep 25, 2026, 5:40 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $10.04 info
Change: -$4.06 (-29%) info
Market Cap: $113.264M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets